CLEVELAND, Sept. 4 /PRNewswire-FirstCall/ -- DATATRAK International,
Inc. (Nasdaq: DATA), a technology company focused on global eClinical
solutions for the clinical trials industry, today reported that it will be
presenting at the Roth Capital Partners 2007 New York City Conference to be
held at the Westin, Times Square, September 5-6. DATATRAK will be
presenting on Thursday afternoon, September 6th at 3:00 P.M. The live
presentation, together with accompanying slides, will be delivered via live
web cast through the Company's web site by clicking on the link labeled
"Click here for live web cast, DATATRAK presents at Roth Capital Partners,
located on the front page of the Company's web site at http://www.datatrak.net.
This web cast will be accessible for 90 days following the scheduled
presentation.
About DATATRAK International
DATATRAK International, Inc. is a worldwide technology company focused
on the provision of multi-component eClinical solutions and related
services for the clinical trials industry. The Company delivers a complete
portfolio of software products that were created in order to accelerate
clinical research data from investigative sites to clinical trial sponsors
and ultimately the FDA, faster and more efficiently than manual methods or
loosely integrated technologies. DATATRAK's eClinical software suite can be
deployed worldwide through an ASP offering or in a licensed Enterprise
Transfer model that fully empowers its clients. The DATATRAK software suite
and its earlier versions have successfully supported hundreds of
international clinical trials involving thousands of clinical research
sites and encompassing tens of thousands of patients in 59 countries.
DATATRAK International, Inc.'s product suite has been utilized in some
aspect of the clinical development of 17 drugs and devices that have
received regulatory approval from either the United States Food and Drug
Administration or counterpart European bodies. DATATRAK International, Inc.
has offices located in Cleveland, Ohio, Bonn, Germany, and Bryan, Texas.
Its common stock is listed on the NASDAQ stock Market under the ticker
symbol "DATA". Visit the DATATRAK International, Inc. web site at
http://www.datatrak.net.
Except for the historical information contained in this press release,
the statements made in this release are forward-looking statements. These
forward-looking statements are made based on management's expectations and
beliefs concerning future events impacting the Company and are subject to
uncertainties and factors (including those specified below) which are
difficult to predict and, in many instances, are beyond the control of the
Company. Factors that may cause actual results to differ materially from
those in the forward-looking statements include the limited operating
history on which the Company's performance can be evaluated; the ability of
the Company to continue to enhance its software products to meet customer
and market needs; fluctuations in the Company's quarterly results; the
viability of the Company's business strategy and its early stage of
development; the timing of clinical trial sponsor decisions to conduct new
clinical trials or cancel or delay ongoing trials; the Company's dependence
on major customers; government regulation associated with clinical trials
and the approval of new drugs; the ability of the Company to compete in the
emerging EDC market; losses that potentially could be incurred from
breaches of contracts or loss of customer data; the inability to protect
intellectual property rights or the infringement upon other's intellectual
property rights; the Company's success in integrating its acquisition's
operations into its own operations and the costs associated with
maintaining and/or developing two product suites; and general economic
conditions such as the rate of employment, inflation, interest rates and
the condition of capital markets. This list of factors is not all
inclusive. In addition, the Company's success depends on the outcome of
various strategic initiatives it has undertaken, all of which are based on
assumptions made by the Company concerning trends in the clinical research
market and the health care industry. The Company undertakes no obligation
to update publicly or revise any forward-looking statement.
SOURCE DATATRAK International, Inc.
 back to top
Related links:
http://www.datatrak.net
CONTACT:
Jeffrey A. Green, Pharm.D., FCP, President
and Chief Executive Officer, +1-440-443-0082 x112; Terry C.
Black, Chief Operating Officer, +1-440-443-0082 x110, both of
DATATRAK International, Inc.; Neal Feagans, Investor Relations of
Feagans Consulting, Inc., +1-303-449-1184, for DATATRAK
International, Inc.
|
